NPs and PAs Can Effectively Manage Diabetes in Primary Care
TUESDAY, Nov. 20, 2018 -- Diabetes outcomes do not differ for patients treated with a primary care provider who is either a physician, nurse practitioner (NP), or physician assistant (PA), according to a study published online Nov. 20 in the Annals of Internal Medicine.
George L. Jackson, Ph.D., from the Durham Veterans Affairs Health Care System in North Carolina, and colleagues used data from the U.S. Department of Veterans Affairs (VA) for 368,481 adult patients with diabetes treated pharmaceutically at 568 VA primary care facilities.
The researchers found that 74.9, 18.2, and 6.9 percent of patients had primary care providers who were physicians, NPs, and PAs, respectively. Compared with those treated by physicians, the differences in hemoglobin A1c values were −0.05 and 0.01 percent for patients treated by NPs and PAs, respectively. For systolic blood pressure, the corresponding differences were −0.08 and 0.02 mm Hg. The corresponding differences were 0.01 and 0.03 mmol/L for low-density lipoprotein-cholesterol. These differences were not clinically significant.
"In conclusion, we found no clinically significant differences in intermediate diabetes outcomes," the authors write. "As a result, this study provides further evidence that using NPs and PAs as primary care providers may represent a mechanism for expanding access to primary care while maintaining quality standards."
© 2020 HealthDay. All rights reserved.
Posted: November 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.